AUTOLOGOUS EX VIVO EXPANDED CD4+-ENRICHED LEUKOCYTES TREATED WITH THE DE-METHYLATING AGENT 5-AZA-DEOXYCYTIDINE
UNII B2NUS89036
Substance Identification & Data
This profile provides standardized clinical and technical data for Autologous Ex Vivo Expanded Cd4+-enriched Leukocytes Treated With The De-methylating Agent 5-aza-deoxycytidine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) B2NUS89036.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Autologous Ex Vivo Expanded Cd4+-enriched Leukocytes Treated With The De-methylating Agent 5-aza-deoxycytidine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.